Elanco Animal Health Incorporated logo

Elanco Animal Health Incorporated (ELAN)

Market Closed
19 Oct, 08:00 PM
NYSE NYSE
$
23. 49
-0.06
-0.2548%
$
11.45B Market Cap
- P/E Ratio
- Div Yield
2.9M Volume
- Eps
$ 23.55
Previous Close
Add Transaction
Day Range
23.46 23.96
Year Range
19.4 27.98
Want to track ELAN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Levi & Korsinsky Reminds Elanco Investors of the Ongoing Investigation into Potential Violations of Securities Laws – ELAN

Levi & Korsinsky Reminds Elanco Investors of the Ongoing Investigation into Potential Violations of Securities Laws – ELAN

NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.

Accesswire | 2 years ago
Shareholders that Lost Money on Elanco Animal Health Incorporated(ELAN) Should Contact Levi & Korsinsky About Securities Fraud Investigation - ELAN

Shareholders that Lost Money on Elanco Animal Health Incorporated(ELAN) Should Contact Levi & Korsinsky About Securities Fraud Investigation - ELAN

NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.

Accesswire | 2 years ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Elanco Animal Health Incorporated - ELAN

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Elanco Animal Health Incorporated - ELAN

NEW YORK, NY / ACCESSWIRE / June 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE:ELAN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Accesswire | 2 years ago
Elanco Animal Health Shares Sink On Unexpected Label Update For Canine Dermatology Drug

Elanco Animal Health Shares Sink On Unexpected Label Update For Canine Dermatology Drug

Elanco Animal Health Incorporated ELAN stock is tumbling as the company released updates to the expected FDA approval timelines for Zenrelia and Credelio Quattro.

Benzinga | 2 years ago
Elanco Animal Health (ELAN) Upgraded to Buy: Here's Why

Elanco Animal Health (ELAN) Upgraded to Buy: Here's Why

Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 2 years ago
US FDA approves Elanco's feed ingredient to cut methane emissions in dairy cows

US FDA approves Elanco's feed ingredient to cut methane emissions in dairy cows

The U.S. Food and Drug Administration has approved Elanco Animal Health's methane-reducing feed ingredient for lactating dairy cows, the company said on Tuesday.

Reuters | 2 years ago